Original Article

Estradiol as an antioxidant: incompatible with its physiological concentrations and function

Correspondence to: Sampath Parthasarathy.

Estradiol has been documented to inhibit the oxidation of low density lipoprotein (LDL). We show that physiological concentrations of estradiol do not inhibit the oxidation of LDL by copper. LDL samples isolated from a) premenopausal and postmenopausal women and from b) women at different time periods during their menstrual cycle, who differ vastly in plasma estradiol levels, were also oxidized at the same rates by copper. In contrast, LDL samples isolated from c) women who were hyperstimulated during in vitro fertilization (IVF), with estradiol concentrations above 2000 pg/ml, were resistant to oxidation by copper. However, these LDL samples were also oxidized at a higher rate by peroxidases. More importantly, subjects with high estradiol levels also showed an increase in myeloperoxidase (MPO) protein in the plasma.

Based on these results, we conclude that at physiologic concentrations, it is unlikely that estradiol could act as an antioxidant. In fact, the ability of estradiol to induce MPO and become a prooxidant might instead suggest that MPO-mediated oxidative clearance of LDL from plasma by liver might favorably influence the outcome of atherosclerosis.—Santanam, N., R. Shern-Brewer, R. McClatchey, P. Z. Castellano, A. A. Murphy, S. Voelkel, and S. Parthasarathy. Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J. Lipid Res. 1998. 39: 2111–2118.

Supplementary key words: atherosclerosis, menopause, coronary artery disease, lipid peroxidation, myeloperoxidase, oxidized low-density lipoprotein

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J D. Alves, E L Radway-Bright, S Lee, B Grima, J Hothersall, C T Ravirajan, and D A Isenberg Antiphospholipid antibodies are induced by in vitro fertilization and correlate with paraoxonase activity and total antioxidant capacity of plasma in infertile women Lupus, May 1, 2005; 14(5): 373 - 380. [Abstract] [PDF]

				R. Makela, P. Dastidar, H. Jokela, M. Saarela, R. Punnonen, and T. Lehtimaki Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Myeloperoxidase Promoter Polymorphism J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3823 - 3828. [Abstract] [Full Text] [PDF]

				V. Vihma, A. Tiitinen, O. Ylikorkala, and M. J. Tikkanen Quantitative Determination of Estradiol Fatty Acid Esters in Lipoprotein Fractions in Human Blood J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2552 - 2555. [Abstract] [Full Text] [PDF]

				C. Hermenegildo, M. C. Garcia-Martinez, J. J. Tarin, and A. Cano Estradiol reduces F2alpha -isoprostane production in cultured human endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2644 - H2649. [Abstract] [Full Text] [PDF]

				I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338. [Abstract] [Full Text] [PDF]

				B. A. Walsh, A. E. Mullick, C. E. Banka, and J. C. Rutledge 17{beta}-Estradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation J. Lipid Res., January 1, 2000; 41(1): 134 - 141. [Abstract] [Full Text]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				M. E. Mendelsohn and R. H. Karas The Protective Effects of Estrogen on the Cardiovascular System N. Engl. J. Med., June 10, 1999; 340(23): 1801 - 1811. [Full Text] [PDF]